Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study
Treatment for infection with hepatitis C virus (HCV) during pregnancy has not yet been approved. Most research on HCV disease burden among women aged 15–49 years focuses on pregnant women. This analysis provides global and national estimates of HCV prevalence in all women of childbearing age. The Eastern Mediterranean region had the highest viraemic prevalence.
